Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Digital Health and Patient Safety, Vienna, Austria.
Wien Klin Wochenschr. 2021 Sep;133(17-18):942-950. doi: 10.1007/s00508-021-01857-4. Epub 2021 Apr 19.
Coronavirus disease 2019 (COVID-19) disrupts routine care and alters treatment pathways in every medical specialty, including intensive care medicine, which has been at the core of the pandemic response. The impact of the pandemic is inevitably not limited to patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their outcomes; however, the impact of COVID-19 on intensive care has not yet been analyzed.
The objective of this propensity score-matched study was to compare the clinical outcomes of non-COVID-19 critically ill patients with the outcomes of prepandemic patients. Critically ill, non-COVID-19 patients admitted to the intensive care unit (ICU) during the first wave of the pandemic were matched with patients admitted in the previous year. Mortality, length of stay, and rate of readmission were compared between the two groups after matching.
A total of 211 critically ill SARS-CoV‑2 negative patients admitted between 13 March 2020 and 16 May 2020 were matched to 211 controls, selected from a matching pool of 1421 eligible patients admitted to the ICU in 2019. After matching, the outcomes were not significantly different between the two groups: ICU mortality was 5.2% in 2019 and 8.5% in 2020, p = 0.248, while intrahospital mortality was 10.9% in 2019 and 14.2% in 2020, p = 0.378. The median ICU length of stay was similar in 2019: 4 days (IQR 2-6) compared to 2020: 4 days (IQR 2-7), p = 0.196. The rate of ICU readmission was 15.6% in 2019 and 10.9% in 2020, p = 0.344.
In this retrospective single center study, mortality, ICU length of stay, and rate of ICU readmission did not differ significantly between patients admitted to the ICU during the implementation of hospital-wide COVID-19 contingency planning and patients admitted to the ICU before the pandemic.
2019 年冠状病毒病(COVID-19)扰乱了每个医学专业的常规护理并改变了治疗途径,包括重症监护医学,这是大流行应对的核心。大流行的影响不可避免地不仅限于严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)感染患者及其结局;然而,COVID-19 对重症监护的影响尚未得到分析。
这项倾向评分匹配研究的目的是比较大流行期间入住重症监护病房(ICU)的非 COVID-19 危重症患者的临床结局与大流行前患者的结局。将大流行期间第一波期间入住 ICU 的非 COVID-19 危重症患者与前一年入院的患者进行匹配。在匹配后比较两组之间的死亡率、住院时间和再入院率。
共纳入 2020 年 3 月 13 日至 5 月 16 日期间入住的 211 例 SARS-CoV-2 阴性危重症患者与从 2019 年 ICU 收治的 1421 例合格患者中选择的 211 例对照进行匹配。匹配后,两组的结局无显著差异:2019 年 ICU 死亡率为 5.2%,2020 年为 8.5%,p=0.248,而院内死亡率为 2019 年为 10.9%,2020 年为 14.2%,p=0.378。2019 年 ICU 中位住院时间相似:4 天(IQR 2-6)与 2020 年相比:4 天(IQR 2-7),p=0.196。2019 年 ICU 再入院率为 15.6%,2020 年为 10.9%,p=0.344。
在这项回顾性单中心研究中,在实施全院 COVID-19 应急计划期间入住 ICU 的患者与大流行前入住 ICU 的患者相比,死亡率、ICU 住院时间和 ICU 再入院率无显著差异。